3-134495351-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PVS1_StrongPM2PP5
The NM_001353108.3(CEP63):c.31C>T(p.Arg11Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,612,752 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001353108.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEP63 | NM_001353108.3 | c.31C>T | p.Arg11Ter | stop_gained | 2/15 | ENST00000675561.1 | NP_001340037.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEP63 | ENST00000675561.1 | c.31C>T | p.Arg11Ter | stop_gained | 2/15 | NM_001353108.3 | ENSP00000502085 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152014Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251416Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135882
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1460738Hom.: 0 Cov.: 30 AF XY: 0.0000110 AC XY: 8AN XY: 726712
GnomAD4 genome AF: 0.0000658 AC: 10AN: 152014Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74238
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 23, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 28, 2022 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 501990). This variant has not been reported in the literature in individuals affected with CEP63-related conditions. This variant is present in population databases (rs763001827, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Arg11*) in the CEP63 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CEP63 are known to be pathogenic (PMID: 21983783, 23936128, 26158450). - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 27, 2015 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at